AGP Executive Report
Last update: 9 hours agoMaternal health & workforce: Sweden and Bangladesh, with UNFPA, backed a UN event pushing midwifery inside primary care, with Bangladesh planning 25,000 midwife posts and a wider prevention-first reform focused on women and children. Cancer care: Health Canada approved epcoritamab (Epkinly) plus lenalidomide and rituximab for relapsed/refractory follicular lymphoma after prior therapy, based on a phase 3 trial showing a major drop in progression or death risk. Neonatal gut protection: A new European study in JAMA Network Open links a multistrain probiotic to lower death/necrotizing enterocolitis risk in premature babies, adding to earlier Netherlands findings. Alzheimer’s testing: Lund University’s Sebastian Palmqvist won a $19.4m NIH grant to develop a blood test using an Alzheimer’s biomarker (MTBR-tau243), aiming for an FDA-ready test within five years. Preventive tech in Sweden’s orbit: Neko Health, a Swedish prevention-focused scan company, opened its first US clinic in New York at $499, offering same-visit results and clinician interpretation. Public health & stigma: The Dutch dictionary added a neutral labia term (“vulvalippen”) after a campaign to replace “schaamlippen” (“shame lips”).
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
